Home > Healthcare > Analytical Instruments > Immunoassay > immunoassay market
Get a free sample of Immunoassay Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Immunoassay Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
These players are developing innovative diagnostic solutions through partnerships and launch initiatives to meet the evolving healthcare demands. These companies are also continuously investing in R&D to enhance immunoassay technologies for driving future advancements in diagnostic accuracy and efficiency.
Foremost players operating in the immunoassay industry are as mentioned below:
North America immunoassay market size is expected to record 5% CAGR through 2032 driven by the growing demand for innovative diagnostic solutions.
The reagents & kits segment in the market is poised to expand at 5.1% CAGR from 2024 to 2032, fueled by the rising usage of immunoassay reagents & kits as integral components of immunoassay procedures to facilitate the detection of specific biomarkers.
Immunoassay Market size was valued at over USD 31.3 billion in 2023 and is estimated to expand at 5.3% CAGR from 2024 to 2032 due to the rise in partnerships and collaborations focused on innovative diagnostics and therapeutic solutions.
Abbott Laboratories, Agilent Technologies, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Luminex Corporation, PerkinElmer, Inc., QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific Inc.